Xylem Statistics
Total Valuation
Xylem has a market cap or net worth of $30.24 billion. The enterprise value is $31.31 billion.
| Market Cap | 30.24B |
| Enterprise Value | 31.31B |
Important Dates
The last earnings date was Tuesday, April 29, 2025, before market open.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | Feb 18, 2025 |
Share Statistics
Xylem has 243.35 million shares outstanding. The number of shares has increased by 4.33% in one year.
| Current Share Class | 243.35M |
| Shares Outstanding | 243.35M |
| Shares Change (YoY) | +4.33% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 0.58% |
| Owned by Institutions (%) | 95.11% |
| Float | 241.71M |
Valuation Ratios
The trailing PE ratio is 33.50 and the forward PE ratio is 26.26. Xylem's PEG ratio is 2.22.
| PE Ratio | 33.50 |
| Forward PE | 26.26 |
| PS Ratio | 3.51 |
| Forward PS | 3.39 |
| PB Ratio | 2.80 |
| P/TBV Ratio | 71.48 |
| P/FCF Ratio | 34.01 |
| P/OCF Ratio | 25.05 |
| PEG Ratio | 2.22 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.13, with an EV/FCF ratio of 35.22.
| EV / Earnings | 34.56 |
| EV / Sales | 3.64 |
| EV / EBITDA | 18.13 |
| EV / EBIT | 27.13 |
| EV / FCF | 35.22 |
Financial Position
The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.19.
| Current Ratio | 1.89 |
| Quick Ratio | 1.30 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 1.14 |
| Debt / FCF | 2.40 |
| Interest Coverage | 30.37 |
Financial Efficiency
Return on equity (ROE) is 8.51% and return on invested capital (ROIC) is 5.60%.
| Return on Equity (ROE) | 8.51% |
| Return on Assets (ROA) | 4.44% |
| Return on Invested Capital (ROIC) | 5.60% |
| Return on Capital Employed (ROCE) | 8.02% |
| Revenue Per Employee | $373,826 |
| Profits Per Employee | $39,391 |
| Employee Count | 23,000 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 5.21 |
Taxes
In the past 12 months, Xylem has paid $204.00 million in taxes.
| Income Tax | 204.00M |
| Effective Tax Rate | 18.41% |
Stock Price Statistics
The stock price has decreased by -5.12% in the last 52 weeks. The beta is 1.10, so Xylem's price volatility has been similar to the market average.
| Beta (5Y) | 1.10 |
| 52-Week Price Change | -5.12% |
| 50-Day Moving Average | 119.21 |
| 200-Day Moving Average | 125.96 |
| Relative Strength Index (RSI) | 66.96 |
| Average Volume (20 Days) | 2,310,558 |
Short Selling Information
The latest short interest is 3.00 million, so 1.23% of the outstanding shares have been sold short.
| Short Interest | 3.00M |
| Short Previous Month | 2.99M |
| Short % of Shares Out | 1.23% |
| Short % of Float | 1.24% |
| Short Ratio (days to cover) | 1.43 |
Income Statement
In the last 12 months, Xylem had revenue of $8.60 billion and earned $906.00 million in profits. Earnings per share was $3.71.
| Revenue | 8.60B |
| Gross Profit | 3.23B |
| Operating Income | 1.15B |
| Pretax Income | 838.00M |
| Net Income | 906.00M |
| EBITDA | 1.73B |
| EBIT | 1.15B |
| Earnings Per Share (EPS) | $3.71 |
Balance Sheet
The company has $1.06 billion in cash and $2.14 billion in debt, giving a net cash position of -$1.08 billion or -$4.43 per share.
| Cash & Cash Equivalents | 1.06B |
| Total Debt | 2.14B |
| Net Cash | -1.08B |
| Net Cash Per Share | -$4.43 |
| Equity (Book Value) | 11.05B |
| Book Value Per Share | 44.44 |
| Working Capital | 1.92B |
Cash Flow
In the last 12 months, operating cash flow was $1.21 billion and capital expenditures -$318.00 million, giving a free cash flow of $889.00 million.
| Operating Cash Flow | 1.21B |
| Capital Expenditures | -318.00M |
| Free Cash Flow | 889.00M |
| FCF Per Share | $3.65 |
Margins
Gross margin is 37.54%, with operating and profit margins of 13.42% and 10.54%.
| Gross Margin | 37.54% |
| Operating Margin | 13.42% |
| Pretax Margin | 12.89% |
| Profit Margin | 10.54% |
| EBITDA Margin | 20.09% |
| EBIT Margin | 13.42% |
| FCF Margin | 10.34% |
Dividends & Yields
This stock pays an annual dividend of $1.60, which amounts to a dividend yield of 1.29%.
| Dividend Per Share | $1.60 |
| Dividend Yield | 1.29% |
| Dividend Growth (YoY) | 9.63% |
| Years of Dividend Growth | 10 |
| Payout Ratio | 43.14% |
| Buyback Yield | -4.33% |
| Shareholder Yield | -3.04% |
| Earnings Yield | 3.00% |
| FCF Yield | 2.94% |
Analyst Forecast
The average price target for Xylem is $145.56, which is 17.15% higher than the current price. The consensus rating is "Buy".
| Price Target | $145.56 |
| Price Target Difference | 17.15% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 5.50% |
| EPS Growth Forecast (5Y) | 13.07% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Xylem has an Altman Z-Score of 4.6 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.6 |
| Piotroski F-Score | 7 |